STONEX GROUP INC (SNEX)

US8618961085 - Common Stock

102.24  +2.21 (+2.21%)

Premarket: 104 +1.76 (+1.72%)

Fundamental Rating

2

Overall SNEX gets a fundamental rating of 2 out of 10. We evaluated SNEX against 222 industry peers in the Capital Markets industry. SNEX may be in some trouble as it scores bad on both profitability and health. SNEX has a decent growth rate and is not valued too expensively.



2

1. Profitability

1.1 Basic Checks

SNEX had positive earnings in the past year.
In the past year SNEX had a positive cash flow from operations.
In the past 5 years SNEX has always been profitable.
In multiple years SNEX reported negative operating cash flow during the last 5 years.

1.2 Ratios

SNEX has a Return On Assets of 0.95%. This is in the lower half of the industry: SNEX underperforms 69.59% of its industry peers.
Looking at the Return On Equity, with a value of 15.26%, SNEX is in the better half of the industry, outperforming 77.88% of the companies in the same industry.
Industry RankSector Rank
ROA 0.95%
ROE 15.26%
ROIC N/A
ROA(3y)1%
ROA(5y)0.97%
ROE(3y)16.92%
ROE(5y)16.97%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SNEX has a Profit Margin of 0.26%. This is in the lower half of the industry: SNEX underperforms 76.50% of its industry peers.
SNEX's Profit Margin has been stable in the last couple of years.
SNEX has a worse Gross Margin (2.26%) than 75.12% of its industry peers.
SNEX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 0.26%
GM 2.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-0.58%
PM growth 5Y0.45%
GM growth 3Y-15.36%
GM growth 5Y-4.84%

0

2. Health

2.1 Basic Checks

SNEX has more shares outstanding than it did 1 year ago.
SNEX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SNEX has a worse debt to assets ratio.

2.2 Solvency

SNEX has a debt to FCF ratio of 25.08. This is a negative value and a sign of low solvency as SNEX would need 25.08 years to pay back of all of its debts.
SNEX has a Debt to FCF ratio of 25.08. This is comparable to the rest of the industry: SNEX outperforms 45.62% of its industry peers.
SNEX has a Debt/Equity ratio of 6.48. This is a high value indicating a heavy dependency on external financing.
SNEX's Debt to Equity ratio of 6.48 is on the low side compared to the rest of the industry. SNEX is outperformed by 87.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.48
Debt/FCF 25.08
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

SNEX has a Current Ratio of 0.56. This is a bad value and indicates that SNEX is not financially healthy enough and could expect problems in meeting its short term obligations.
SNEX's Current ratio of 0.56 is on the low side compared to the rest of the industry. SNEX is outperformed by 72.35% of its industry peers.
SNEX has a Quick Ratio of 0.56. This is a bad value and indicates that SNEX is not financially healthy enough and could expect problems in meeting its short term obligations.
SNEX's Quick ratio of 0.56 is on the low side compared to the rest of the industry. SNEX is outperformed by 72.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.56

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.06% over the past year.
The Earnings Per Share has been growing by 13.27% on average over the past years. This is quite good.
Looking at the last year, SNEX shows a very strong growth in Revenue. The Revenue has grown by 64.14%.
The Revenue has been growing by 24.87% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)17.06%
EPS 3Y10.69%
EPS 5Y13.27%
EPS Q2Q%47.46%
Revenue 1Y (TTM)64.14%
Revenue growth 3Y32.92%
Revenue growth 5Y24.87%
Sales Q2Q%12.66%

3.2 Future

The Earnings Per Share is expected to grow by 2.02% on average over the next years.
The Revenue is expected to grow by 0.63% on average over the next years.
EPS Next Y3.04%
EPS Next 2Y2.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.55%
Revenue Next 2Y0.63%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.84 indicates a correct valuation of SNEX.
Compared to the rest of the industry, the Price/Earnings ratio of SNEX is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.28. SNEX is valued rather cheaply when compared to this.
SNEX is valuated correctly with a Price/Forward Earnings ratio of 12.47.
SNEX's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of SNEX to the average of the S&P500 Index (23.53), we can say SNEX is valued slightly cheaper.
Industry RankSector Rank
PE 12.84
Fwd PE 12.47

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, SNEX is valued a bit cheaper than 76.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.39
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.23
PEG (5Y)0.97
EPS Next 2Y2.02%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SNEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STONEX GROUP INC

NASDAQ:SNEX (1/14/2025, 8:06:03 PM)

Premarket: 104 +1.76 (+1.72%)

102.24

+2.21 (+2.21%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-19 2024-11-19/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners79.66%
Inst Owner Change-0.07%
Ins Owners10.29%
Ins Owner Change0.78%
Market Cap3.26B
Analysts85.71
Price Target113.22 (10.74%)
Short Float %1.58%
Short Ratio2.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.19%
Min EPS beat(2)3.43%
Max EPS beat(2)10.95%
EPS beat(4)4
Avg EPS beat(4)9.97%
Min EPS beat(4)2.44%
Max EPS beat(4)23.05%
EPS beat(8)7
Avg EPS beat(8)9.9%
EPS beat(12)11
Avg EPS beat(12)24.53%
EPS beat(16)12
Avg EPS beat(16)14.72%
Revenue beat(2)1
Avg Revenue beat(2)1.26%
Min Revenue beat(2)-3.69%
Max Revenue beat(2)6.22%
Revenue beat(4)2
Avg Revenue beat(4)-4.66%
Min Revenue beat(4)-24.32%
Max Revenue beat(4)6.22%
Revenue beat(8)5
Avg Revenue beat(8)416.03%
Revenue beat(12)9
Avg Revenue beat(12)1894.47%
Revenue beat(16)13
Avg Revenue beat(16)2360.04%
PT rev (1m)0%
PT rev (3m)23.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)26.24%
EPS NY rev (1m)0%
EPS NY rev (3m)8.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)11.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.05%
Valuation
Industry RankSector Rank
PE 12.84
Fwd PE 12.47
P/S 0.03
P/FCF 7.39
P/OCF 6.44
P/B 1.91
P/tB 2
EV/EBITDA N/A
EPS(TTM)7.96
EY7.79%
EPS(NY)8.2
Fwd EY8.02%
FCF(TTM)13.83
FCFY13.53%
OCF(TTM)15.88
OCFY15.53%
SpS3128.34
BVpS53.53
TBVpS51
PEG (NY)4.23
PEG (5Y)0.97
Profitability
Industry RankSector Rank
ROA 0.95%
ROE 15.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.26%
GM 2.26%
FCFM 0.44%
ROA(3y)1%
ROA(5y)0.97%
ROE(3y)16.92%
ROE(5y)16.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-0.58%
PM growth 5Y0.45%
GM growth 3Y-15.36%
GM growth 5Y-4.84%
F-Score4
Asset Turnover3.64
Health
Industry RankSector Rank
Debt/Equity 6.48
Debt/FCF 25.08
Debt/EBITDA N/A
Cap/Depr 122.79%
Cap/Sales 0.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 169.36%
Current Ratio 0.56
Quick Ratio 0.56
Altman-Z N/A
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)108.75%
Cap/Depr(5y)116.13%
Cap/Sales(3y)0.07%
Cap/Sales(5y)0.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.06%
EPS 3Y10.69%
EPS 5Y13.27%
EPS Q2Q%47.46%
EPS Next Y3.04%
EPS Next 2Y2.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)64.14%
Revenue growth 3Y32.92%
Revenue growth 5Y24.87%
Sales Q2Q%12.66%
Revenue Next Year1.55%
Revenue Next 2Y0.63%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y725.64%
FCF growth 3Y-40.15%
FCF growth 5Y19.18%
OCF growth 1Y2238.82%
OCF growth 3Y-37.96%
OCF growth 5Y20.98%